Identifying preventative measures against frailty, locomotive syndrome, and sarcopenia in young adults: a pilot study.
Tomohiro Yasuda
PMID 34776616WHAT IT FOUND
Most healthy young adults in this pilot showed signs of pre-frailty or low muscle mass, but very few had actual sarcopenia or severe mobility loss.
The findings suggest monitoring muscle mass early, though the small, young sample limits broad application.
Key findings
01The prevalence of frailty-prefrailty was higher than that of presarcopenia and locomotive syndrome in the study population.
02No participants met the criteria for sarcopenia or stage 2 locomotive syndrome, indicating that functional decline was rare among these healthy young adults.
03Approximately 60% of the healthy young adults were identified as having any or all three diagnostic criteria for frailty, sarcopenia, or locomotive syndrome.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study is a pilot with a small sample size of 83 participants. The population was limited to healthy Japanese university students aged 18 to 20, so results may not generalize to other ages, ethnicities, or health statuses. The number of male participants was small (18), making it difficult to discuss gender differences robustly. The diagnostic criteria used were originally designed for older adults and applied to young adults, which may not be fully validated for this age group.
Declared interests
The author declares no conflict of interest. The study was partially supported by grants from the Japan Ministry of Education, Culture, Sports, Science, and Technology and Seirei Christopher University.
The easy way to misread this
Do not interpret the high prevalence of pre-frailty and presarcopenia as evidence that these young adults are currently disabled or at immediate risk of falls. These are early warning signs in a healthy population, not a diagnosis of disease, and the study did not test any intervention.